Literature DB >> 25318600

Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis.

Chenggang Wei1, Jieying Tan, Li Xu, Liu Juan, Si Wei Zhang, Lu Wang, Qun Wang.   

Abstract

We aim to investigate the diagnostic capability of diffusion-weighted imaging using parallel acquisition technique for the differentiation between hepatic metastases and benign focal lesions with a meta-analysis. The meta-analysis included a total of 858 hepatic metastases and 440 benign liver lesions from nine studies. The pooled sensitivity and specificity of diffusion-weighted imaging (DWI) were 0.87 (95% CI, 0.84-0.89) and 0.90 (95% CI, 0.87-0.93), respectively. The positive likelihood ratio (PLR) and negative likelihood ratio (NLR) were 8.50 (95% CI, 4.97-14.52) and 0.17 (95% CI, 0.11-0.26), respectively. The P value for χ (2) heterogeneity for all pooled estimates was <0.05. From the fitted summary receiver operating characteristics (SROC), the area under the curve (AUC) and Q* index were 0.95 and 0.88, respectively. Publication bias is not present (t = -0.76, P = 0.471). The meta-regression analysis indicated that evaluated covariates included patient number, patient population, mean age, maximum of b factor, number of cysts, number of hemangiomas, and field were not sources of heterogeneity (all P value >0.05). Diffusion-weighted imaging was useful for differentiation between hepatic metastases and benign focal lesions. The diffusion characteristics of the benign hepatocellular lesions, including cases of focal nodular hyperplasia (FNH) and adenoma, have rarely been reported and need further studies. The diagnostic capability of DWI with parallel acquisition technique for differentiation between metastases and benign hepatic focal lesions might be overestimated.

Entities:  

Mesh:

Year:  2014        PMID: 25318600     DOI: 10.1007/s13277-014-2663-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  27 in total

1.  Forest plots: data summaries at a glance.

Authors:  Julie Yeh; Frank D'Amico
Journal:  J Fam Pract       Date:  2004-12       Impact factor: 0.493

2.  Diffusion-weighted imaging versus superparamagnetic iron oxide (SPIO)-enhanced MRI: exclusive and combined values in the assessment of hepatic metastases.

Authors:  Hana Kim; Jeong-Sik Yu; Eun-Suk Cho; Jae-Joon Chung; Joo Hee Kim; Dae Jung Kim; Jhii-Hyun Ahn; Ki Whang Kim
Journal:  Magn Reson Imaging       Date:  2012-02-06       Impact factor: 2.546

3.  Forest and funnel plots illustrated the calibration of a prognostic model: a descriptive study.

Authors:  Kwok Ming Ho
Journal:  J Clin Epidemiol       Date:  2007-02-26       Impact factor: 6.437

Review 4.  Diffusion-weighted imaging of the liver: a comprehensive review.

Authors:  Lorenzo Mannelli; Puneet Bhargava; Sherif F Osman; Eytan Raz; Mariam Moshiri; Giacomo Laffi; Gregory J Wilson; Jeffrey H Maki
Journal:  Curr Probl Diagn Radiol       Date:  2013 May-Jun

5.  Value of diffusion-weighted magnetic resonance images for discrimination of focal benign and malignant hepatic lesions: a meta-analysis.

Authors:  Dong Xia; Jiyong Jing; Haiping Shen; Jianjun Wu
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

6.  Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI.

Authors:  Andrew D Hardie; Mohit Naik; Elizabeth M Hecht; Hersh Chandarana; Lorenzo Mannelli; James S Babb; Bachir Taouli
Journal:  Eur Radiol       Date:  2010-02-11       Impact factor: 5.315

7.  Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases.

Authors:  Kotaro Shimada; Hiroyoshi Isoda; Yuusuke Hirokawa; Shigeki Arizono; Toshiya Shibata; Kaori Togashi
Journal:  Eur Radiol       Date:  2010-06-20       Impact factor: 5.315

8.  Differential diagnosis between malignant and benign hepatic tumors using apparent diffusion coefficient on 1.5-T MR imaging: a meta analysis.

Authors:  Youwei Li; Zhengguang Chen; Jichen Wang
Journal:  Eur J Radiol       Date:  2011-02-18       Impact factor: 3.528

9.  External validation of two nomograms for predicting patient survival after hepatic resection for metastatic colorectal cancer.

Authors:  Yuji Takakura; Masazumi Okajima; Yukihide Kanemitsu; Shintaro Kuroda; Hiroyuki Egi; Takao Hinoi; Hirotaka Tashiro; Hideki Ohdan
Journal:  World J Surg       Date:  2011-10       Impact factor: 3.352

10.  Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation.

Authors:  A R Gillams; W R Lees
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

View more
  11 in total

1.  Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.

Authors:  Stuart A Taylor; Susan Mallett; Anne Miles; Stephen Morris; Laura Quinn; Caroline S Clarke; Sandy Beare; John Bridgewater; Vicky Goh; Sam Janes; Dow-Mu Koh; Alison Morton; Neal Navani; Alfred Oliver; Anwar Padhani; Shonit Punwani; Andrea Rockall; Steve Halligan
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

2.  Further considerations on hepatic lesion discrimination using diffusion MR imaging.

Authors:  Zhenyin Liu; Jing Zhang
Journal:  Tumour Biol       Date:  2015-11

3.  1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis.

Authors:  Xin Wang; Xiang Jiang Wang; Hui Sheng Song; Long Hua Chen
Journal:  Med Oncol       Date:  2015-04-21       Impact factor: 3.064

Review 4.  Updates on Imaging of Liver Tumors.

Authors:  Arya Haj-Mirzaian; Ana Kadivar; Ihab R Kamel; Atif Zaheer
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

5.  Standard-b-value vs low-b-value DWI for differentiation of benign and malignant vertebral fractures: a meta-analysis.

Authors:  Zhanpeng Luo; Li Litao; Suxi Gu; Xiaobo Luo; Dawei Li; Long Yu; Yuanzheng Ma
Journal:  Br J Radiol       Date:  2015-11-27       Impact factor: 3.039

6.  Effect of combination therapy of siRNA targeting growth hormone receptor and 5-fluorouracil in hepatic metastasis of colon cancer.

Authors:  Dong Zhou; Y I Zhang; Daoming Liang; Yong Yuan; Demiao Zeng; Jiayong Chen; Jie Yang
Journal:  Oncol Lett       Date:  2015-09-30       Impact factor: 2.967

7.  Assessment of different mathematical models for diffusion-weighted imaging as quantitative biomarkers for differentiating benign from malignant solid hepatic lesions.

Authors:  Yao Hu; Hao Tang; Haojie Li; Anqin Li; Jiali Li; Daoyu Hu; Zhen Li; Ihab R Kamel
Journal:  Cancer Med       Date:  2018-05-07       Impact factor: 4.452

8.  Diagnostic Performance of Diffusion-Weighted Imaging for Differentiating Malignant From Benign Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Systematic Review and Meta-Analysis.

Authors:  Fan Xu; Yingying Liang; Wei Guo; Zhiping Liang; Liqi Li; Yuchao Xiong; Guoxi Ye; Xuwen Zeng
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

Review 9.  Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates.

Authors:  Anuradha Shenoy-Bhangle; Vinit Baliyan; Hamed Kordbacheh; Alexander R Guimaraes; Avinash Kambadakone
Journal:  World J Hepatol       Date:  2017-09-18

10.  Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer - DIA-PANC study: study protocol for an international, multicenter, diagnostic trial.

Authors:  G Litjens; D M Rivière; E J M van Geenen; S A Radema; L A A Brosens; M Prokop; C J H M van Laarhoven; J J Hermans
Journal:  BMC Cancer       Date:  2020-08-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.